Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Fernas
    Member
    • Apr 2013
    • 74

    RNASeq: Multiple identical uniquely mapped reads

    Hi all,

    My question is about processing RNASeq data in order to extract the normal gene expression count matrix:

    if two reads are mapped uniquely to the same genome position and both of them have identical alignment region. Shall we count them as 2 reads or simply 1.

    If you say that we count them as 2 reads, then my question: why in Chipseq processing, we count these 2 reads as only 1 to remove the PCR bias problem which may cause such duplicates.
  • Chipper
    Senior Member
    • Mar 2008
    • 323

    #2
    Originally posted by Fernas View Post
    Hi all,

    My question is about processing RNASeq data in order to extract the normal gene expression count matrix:

    if two reads are mapped uniquely to the same genome position and both of them have identical alignment region. Shall we count them as 2 reads or simply 1.

    If you say that we count them as 2 reads, then my question: why in Chipseq processing, we count these 2 reads as only 1 to remove the PCR bias problem which may cause such duplicates.
    De-duplication would not let you analyze highly expressed transcripts which will need to have many identical reads. If you think your RNA-seq sample has a high PCR duplication rate it is better to downsample it.

    Comment

    • Fernas
      Member
      • Apr 2013
      • 74

      #3
      Thanks @chipper.
      But I am still wondering why in Chipseq processing steps, we remove duplicates, however, in RNASeq we keep them.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...